解读新版变应性鼻炎诊疗指南中白三烯受体拮抗剂的临床应用

李华斌; 张佳

doi:10.13201/j.issn.1001-1781.2016.09.003

解读新版变应性鼻炎诊疗指南中白三烯受体拮抗剂的临床应用

李华斌^,,
张佳

- 上海交通大学医学院附属新华医院耳鼻咽喉-头颈外科(上海, 200092)
基金项目:
国家科技支撑计划（No：2014BAI07B04）

详细信息

通讯作者: 李华斌,E-mail:noseli@163.com

中图分类号: R765.21

收稿日期: 2016-03-02

Summary on the indication of leukotriene receptor agonist in the novel guideline for allergic rhinitis

LI Huabin^,,
ZHANG Jia

More Information

Corresponding author: LI Huabin, E-mail: noseli@163.com

Received Date: 02 March 2016

摘要

- 鼻炎,变应性 /
- 白三烯受体拮抗剂
- rhinitis, allergic /
- leukotriene receptor agonist

HTML全文

参考文献(21)

[1]	李华斌.变应性鼻炎的发病机制及诊疗进展[J].中华耳鼻咽喉头颈外科杂志,2014,49(5):347-352.
[2]	中华耳鼻咽喉头颈外科杂志编委会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎诊断和治疗指南(2009年,武夷山)[J].中华耳鼻咽喉头颈外科杂志,2009,44(12):977-978.
[3]	中华耳鼻咽喉头颈外科杂志编委会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎诊断和治疗指南(2015年,天津)[J].中华耳鼻咽喉头颈外科杂志,2016,51(1):6-24.
[4]	GREINER A N,HELLINGS P W,ROTIROTI G,et al.Allergic rhinitis[J].Lancet,2011,378:2112-2122.
[5]	OGAWA Y,CALHOUN W J.The role of leukotrienes in airway inflammation[J].J Allergy Clin Immunol,2006,118:789-798.
[6]	SCOW D T,LUTTERMOSER G K,DICKERSON K S.Leukotriene inhibitors in the treatment of allergy and asthma[J].Am Fam Physician,2007,75:65-70.
[7]	TOPUZ B,OGMEN G G.Montelukast as an adjuvant to mainstay therapies in patients with seasonal allergic rhinitis[J].Clin Exp Allergy,2003,33:823-826.
[8]	HABERAL I,COREY J P.The role of leukotrienes in nasal allergy[J].Otolaryngol Head Neck Surg,2003,129:274-279.
[9]	CHERVINSKY P,PHILIP G,MALICE M P,et al.Montelukast for treating fall allergic rhinitis:effect of pollen exposure in 3studies[J].Ann Allergy Asthma Immunol,2004,92:367-373.
[10]	VAN ADELSBERG J,PHILIP G,PEDINOFF A J,et al.Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period[J].Allergy,2003,58:1268-1276.
[11]	PATEL P,PHILIP G,YANG W,et al.Randomized,double-blind,placebo-controlled study of montelukast for treating perennial allergic rhinitis[J].Ann Allergy Asthma Immunol,2005,95:551-7.
[12]	陆忆,殷敏,程雷.白三烯受体拮抗剂孟鲁司特治疗变应性鼻炎的荟萃分析[J].中华耳鼻咽喉头颈外科杂志,2014,49(9):659-667.
[13]	BOUSQUET J,KHALTAEV N,CRUZ A A,et al.Allergic Rhinitis and Its Impact on Asthma(ARIA)2008update(in collaboration with the World Health Organization,GA(2)LEN and AllerGen)[J].Allergy,2008,63(suppl 86):8-160.
[14]	OKUBO K,KURONO Y,FUJIEDA S,et al.Japanese Guideline for Allergic Rhinitis 2014[J].Allergol Int,2014,63:357-375.
[15]	NAYAK A,LANGDON R B.Montelukast in the treatment of allergic rhinitis:an evidence-based review[J].Drugs,2007,67:887-901.
[16]	程雷.变应性鼻炎诊疗指南的修订要点及意义[J].中华耳鼻咽喉头颈外科杂志,2016,51(1):2-5.
[17]	PHILIP G,MALMSTROM K,HAMPEL F C,et al.Montelukast for treating seasonal allergic rhinitis:a randomized,double-blind,placebo-controlled trial performed in the spring[J].Clin Exp Allergy,2002,32:1020-1028.
[18]	CHEN S T,LU K H,SUN H L,et al.Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6year[J].Pediatr Allergy Immunol,2006,17:49-54.
[19]	冯韶燕,樊韵平,李磊,等.白三烯受体拮抗剂联合鼻用激素治疗变应性鼻炎的系统评价[J].临床耳鼻咽喉头颈外科杂志,2015,29(3):207-111.
[20]	PINAR E,ERYIGIT O,ONCEL S,et al.Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis[J].Auris Nasus Larynx,2008,35:61-66.
[21]	PHILIP G,HUSTAD C M,MALICE M P,et al.Analysis of behavior-related adverse experiences in clinical trials of montelukast[J].J Allergy Clin Immunol,2009,124:699-706.